دراسة تغيرات بعض القيم الدموية لدى مريضات الورم الليفي الرحمي
Abstract
- أجريت هذه الدراسة في مشفى الأسد الجامعي في اللاذقية عام 2013 وهي دراسة استرجاعية لمريضات الورم الليفي الرحمي اللواتي قبلن في قسم التوليد وأمراض النساء خلال الفترة بين 1/6/2011 و1/6/2013 .
- شملت الدراسة 103 مريضة . تم توثيق المعلومات الخاصة بكل مريضة : العمر، الأعراض والعلامات، عدد الحمول و الولادات ، السوابق المرضية، الفحص السريري و النسائي ، الإيكو ، التحاليل الدموية : الخضاب و الهيماتوكريت وقيم الكرية الحمراء، نوع العلاج الجراحي المجرى.
- بلغت نسبة انتشار الورم الليفي في هذه الدراسة 5.1 % .
- أشيع مظاهره النزف التناسلي الشاذ حيث بلغت نسبته 63.1 % من مجمل التظاهرات السريرية.
- كان خضاب الدم أقل من 12 غ/دل لدى 61 مريضة منم ريضات الدراسة أي بنسبة 59.22%.
- كانت قيمة الهيماتوكريت أقل من 36 % لدى 59 مريضة من مريضات الدراسة أي بنسبة 57.28 % .
- وهذا يؤكد أن مريضات الورم الليفي الرحمي عاليات الخطورة للإصابة بفقر الدم (اعتمدنا على القيم الحدية للخضاب والهيماتوكريت CUT OFF POINT التي وضعتها منظمة الصحة العالمية WHO) , وهو فقر دم بعوز الحديد لأن وسطي قيم الكرية الحمراء أقل من الطبيعي.
- استئصال الورم الليفي هو الخيار الجراحي لدى الشابات اللواتي يرغبن بالإنجاب أو يردن الحفاظ على الطمث، بينما استئصال الرحم البطني أو المهبلي هو الخيار الجراحي لدى المسنات أو من أتممن حياتهن الإنجابية.
- This study was carried at Al Assad hospital, Lattakia. It is a retrospective study of uterine leiomyoma patients who had been accepted in the Department of Gynecology during the period between 1/6/2011 and 1/6/2013 .
- The study included 103 patients. We documented information for each patient: age, signs and symptoms, number of pregnancies and births, clinical and vaginal examination, ultrasound, blood tests: hemoglobin, hematocrit and red cell values, and the type of surgical treatment.
- The prevalence of uterine leiomyoma in this study was 5.1%.
- The most clinical manifestation of uterine leiomyoma was abnormal uterine bleeding (63.1 %).
- Hemoglobin was less than 12 g / dL at 59.22% of cases.
- Hematocrit was less than 36% at 57.28 % of cases.
- This confirms that uterine leiomyoma patients are at high risk of anemia,
(we depended on cut off point of WHO for hemoglobin and hematocrit), and the anemia is by iron deficiency because the average values of red blood cells were less than normal. - Myomectomy is the surgical option among young women who want to reproduce or maintain menstruation, while abdominal and vaginal hysterectomy are surgical options for older women or who have completed their reproductive life .
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.